Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
Watch Live

Military

Artificial Blood Platelets Could Save Lives Of Troops Injured In Combat

Researchers use bacteria growing on the plate as a tool for evolving molecules such as antibodies.
Georgia Tech
Researchers use bacteria growing on the plate as a tool for evolving molecules such as antibodies.

Scientists are working on developing artificial blood platelets that could better help troops injured in combat survive their wounds, according to news out of the Georgia Institute of Technology.

A group of researchers from Georgia Tech and Emory University, both in Atlanta, have a project in the works that could one day give service members with traumatic injuries the ability to treat their own wounds:

[T]hey're developing new biomaterials, including artificial blood platelets laced with regulatory chemicals that could be included in an injector device the size of an iPhone.

Soldiers wounded in action could use the device to treat themselves, helping control bleeding, stabilizing the injury and setting the right course for healing. wounded in action could use the device to treat themselves, helping control bleeding, stabilizing the injury and setting the right course for healing.
So far, the artificial platelets have only been tested in rats, and researchers admit getting things to a point where humans could use the technology is a ways off. Still, scientists are optimistic their research will one day lead to a startup company transitioning their discoveries into real-world use.

According to Thomas Barker, associate professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University:

Advertisement
"You could have it literally in the pocket of any soldier, who could pop it out when needed. As the needle is extended, you would break the package of freeze-dried particles. The device would then be placed on the abdomen, where the particles would be injected into the bloodstream. They would circulate inactive until they encountered the initiation of clotting."

The Department of Defense and the National Institutes of Health are funding the research.